G9a-IN-1

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

G9a-IN-1 

G9a-IN-1 (Compound 113) 是一种 G9a 蛋白抑制剂。G9A (也称为 EHMT2) 是一种核组蛋白赖氨酸甲基转移酶，可催化组蛋白 H3 赖氨酸 9 二甲基化 (H3K9me2)，这是与转录基因沉默相关的可逆修饰。G9a-IN-1可用于自身免疫性疾病或癌症的研究。

G9a-IN-1

G9a-IN-1 Chemical Structure

CAS No. : 1350752-07-6

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

G9a-IN-1 (Compound 113) is a G9a protein inhibitor. G9A/EHMT2 is a nuclear histone lysine methyltransferase that catalyzes histone H3 lysine 9 dimethylation (H3K9me2), which is a reversible modification generally associated with transcriptional gene silencing. G9a-IN-1 can be used for the research of autoimmune disorders or cancer[1].

分子量

462.03

Formula

C24H36ClN5O2
CAS 号

1350752-07-6
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Dimitrios Iliopoulos, et al. Small molecules for the treatment of autoimmune diseases and cancer. WO2022031939A1

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务